Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00127296
Status:
COMPLETED
Last Update Posted:
2017-01-06
First Post:
2005-08-03
Brief Title:
Reliability of Dosing With NovoLog Mix 7030 FlexPen Compared With Vial and Syringe
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Study Overview
Official Title:
Comparison of the Accuracy and Precision of NovoLog Mix 7030 FlexPen to Vial and Syringe in Patients With Type 2 Diabetes Mellitus
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial is conducted in the United States of America USA The aim of this trial is to compare desired target with actual target amounts of insulin dispensed using NovoLog Mix 7030 FlexPen and vial and syringe in subjects with type 2 diabetes mellitus No insulin is administered in this trial - insulin is dispensed into an empty vial
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None